Fed up with the healthcare industry, this red state capped insulin prices for patients

In North Dakota, a rare bipartisan effort has led to capping insulin prices for diabetes patients, reflecting a broader push across the country to make life-saving medications more affordable. This move comes as a response to the exorbitant costs that have been placing a significant financial burden on individuals with diabetes. By setting a maximum price for insulin, the state aims to alleviate the economic strain on patients and underscore the importance of accessible healthcare, regardless of political affiliation. This development could inspire other states to follow suit and address the urgent need for more affordable medications nationwide.